{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Inhaled+Symbicort+Dose+1", "query": { "intervention": "Inhaled Symbicort Dose 1" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Inhaled+Symbicort+Dose+1&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-20T20:46:01.044Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02189304", "title": "Pharmacokinetics and Safety Study of PT010 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COPD" ], "interventions": [ { "name": "PT010", "type": "DRUG" }, { "name": "PT009", "type": "DRUG" }, { "name": "Symbicort Turbohaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 59, "start_date": "2014-06-01", "completion_date": "2014-09-01", "has_results": false, "last_update_posted_date": "2018-06-13", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02189304" }, { "nct_id": "NCT00915538", "title": "Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "pMDI budesonide/formotrol 160/4.5 is in group 1", "type": "DRUG" }, { "name": "Symbicort 160/4.5 plus Aerochamber Plus included in group 2", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Western Sky Medical Research", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 16, "start_date": "2009-07", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2020-08-13", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 1, "location_summary": "El Paso, Texas", "locations": [ { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00915538" }, { "nct_id": "NCT01980615", "title": "Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Inhaled BGF (PT010) Dose 1", "type": "DRUG" }, { "name": "Inhaled BGF (PT010) Dose 2", "type": "DRUG" }, { "name": "Inhaled BGF (PT010) Dose 3", "type": "DRUG" }, { "name": "Inhaled GFF (PT003)", "type": "DRUG" }, { "name": "Inhaled Symbicort Dose 1", "type": "DRUG" }, { "name": "Inhaled Symbicort Dose 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pearl Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 84, "start_date": "2013-11", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-04-14", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01980615" }, { "nct_id": "NCT06272370", "title": "Individualizing Treatment for Asthma in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma", "Bronchial Diseases", "Respiratory Tract Infections", "Lung Diseases, Obstructive", "Lung Diseases", "Respiratory Hypersensitivity", "Immune System Diseases" ], "interventions": [ { "name": "Asthma Symptom Monitoring online tools", "type": "OTHER" }, { "name": "Inhaled Steroids", "type": "DRUG" }, { "name": "Azithromycin Pill", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "DARTNet Institute", "sponsor_class": "OTHER_GOV", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 103, "start_date": "2024-02-01", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2025-04-20", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06272370" }, { "nct_id": "NCT03015259", "title": "Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Budesonide/Formoterol fumarate dihydrate", "type": "DRUG" }, { "name": "Symbicort", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kindeva Drug Delivery", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1762, "start_date": "2016-12-29", "completion_date": "2018-02-08", "has_results": true, "last_update_posted_date": "2022-08-24", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 95, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tempe, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03015259" }, { "nct_id": "NCT02573233", "title": "Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Dupilumab SAR231893/REGN668", "type": "DRUG" }, { "name": "fluticasone propionate and salmeterol", "type": "DRUG" }, { "name": "budesonide and formoterol", "type": "DRUG" }, { "name": "mometasone furoate and formoterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2016-01-27", "completion_date": "2018-01-03", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 6, "location_summary": "Tucson, Arizona • Denver, Colorado • Boston, Massachusetts + 3 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573233" }, { "nct_id": "NCT07433569", "title": "A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Budesonide/formoterol fumarate Aerosphere", "type": "COMBINATION_PRODUCT" }, { "name": "Budesonide/formoterol fumarate pMDI", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "4 Years to 12 Years" }, "enrollment_count": 16, "start_date": "2026-03-05", "completion_date": "2026-06-26", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 6, "location_summary": "Long Beach, California • Miami, Florida • Lafayette, Louisiana + 3 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Boerne", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07433569" }, { "nct_id": "NCT01136655", "title": "A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "80/2.25 μg Symbicort pMDI", "type": "DRUG" }, { "name": "80/4.5 μg Symbicort pMDI", "type": "DRUG" }, { "name": "Foradil Aerolizer 12 μg", "type": "DRUG" }, { "name": "40 μg budesonide HFA pMDI", "type": "DRUG" }, { "name": "placebo HFA pMDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 54, "start_date": "2010-09", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2013-10-31", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 20, "location_summary": "Huntington, California • Long Beach, California • Mission Viejo, California + 17 more", "locations": [ { "city": "Huntington", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Rolling Hills Estate", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01136655" }, { "nct_id": "NCT00576069", "title": "Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "fluticasone/salmeterol", "type": "DRUG" }, { "name": "mometasone/formoterol", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "10 Years to 95 Years" }, "enrollment_count": 60, "start_date": "2007-10-25", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576069" }, { "nct_id": "NCT06473779", "title": "Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Severe Asthma" ], "interventions": [ { "name": "Tezepelumab", "type": "COMBINATION_PRODUCT" }, { "name": "Budesonide/formoterol", "type": "COMBINATION_PRODUCT" }, { "name": "Albuterol/budesonide (AIRSUPRA®)", "type": "COMBINATION_PRODUCT" }, { "name": "Mannitol", "type": "COMBINATION_PRODUCT" }, { "name": "Salbutamol", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 326, "start_date": "2024-09-30", "completion_date": "2027-06-25", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-09-20T20:46:01.044Z", "location_count": 8, "location_summary": "Palmdale, California • Colorado Springs, Colorado • Miami, Florida + 5 more", "locations": [ { "city": "Palmdale", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06473779" } ] }